OS THERAPIES INCORPORATED Adjustments to Additional Paid in Capital, Warrant Issued
OS THERAPIES INCORPORATED (OSTX) reported Adjustments to Additional Paid in Capital, Warrant Issued of $878.15 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-08-14
- OS THERAPIES INCORPORATED adjustments to additional paid in capital, warrant issued for the quarter ending 2025-06-30 was $878.15K.
- OS THERAPIES INCORPORATED adjustments to additional paid in capital, warrant issued for the quarter ending 2025-03-31 was $330.78K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 3 month as first filed | Adjustments to Additional Paid in Capital, Warrant Issued 6 month |
|---|---|---|---|
| 2025-06-30 | $878.15K 10-Q · filed 2026-08-14 | $2.90M 10-Q · filed 2025-08-18 | $1.21M derived: sum of 2 quarters · filed 2026-08-14 |
| 2025-03-31 | $330.78K 10-Q · filed 2025-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |